Search research articles
Contact Us
Filters
Showing results (21-30 of 70) with videos related to
Page
of 7
Sort By:
Progress in Clinical and Biological Research
|
January 1, 1992
Incidence of bacterial contamination of bone marrow grafts
K G Schepers, J M Davis, S D Rowley
Blood
|
July 1, 1986
Dye-mediated photolysis of human neuroblastoma cells: implications for autologous bone marrow transplantation
F Sieber, S Rao, S D Rowley, et al.
The American Journal of Pediatric Hematology/Oncology
|
January 1, 1990
Ex vivo chemopurging of autologous bone marrow with 4-hydroperoxycyclophosphamide to eliminate occult leukemic cells. Laboratory and clinical observations
A M Yeager, S D Rowley, H Kaizer, et al.
Blood
|
July 1, 1993
Hematopoietic precursors resistant to treatment with 4-hydroperoxycyclophosphamide: requirement for an interaction with marrow stroma in addition to hematopoietic growth factors for maximal generation of colony-forming activity
S D Rowley, C Brashem-Stein, R Andrews, et al.
Blood
|
March 1, 1987
Culture from human bone marrow of blast progenitor cells with an extensive proliferative capacity
S D Rowley, S J Sharkis, C Hattenburg, et al.
Blood
|
May 1, 1994
Effect of cell concentration on bone marrow and peripheral blood stem cell cryopreservation
S D Rowley, W I Bensinger, T A Gooley, et al.
Bone Marrow Transplantation
|
March 1, 1996
Long-term cryopreservation of bone marrow for autologous transplantation
H Attarian, Z Feng, C D Buckner, et al.
Transfusion Science
|
February 6, 1998
Protein A immunoadsorption in alloimmunized patients refractory to platelet transfusions and in patients with treatment-resistant immune thrombocytopoenic purpura
K Gutensohn, A R Zander, S D Rowley, et al.
Transfusion
|
May 21, 1999
The predictive value of white cell or CD34+ cell count in the peripheral blood for timing apheresis and maximizing yield
J Yu, W Leisenring, W I Bensinger, et al.
Cytotherapy
|
April 30, 2010
Post-thaw removal of DMSO does not completely abrogate infusional toxicity or the need for pre-infusion histamine blockade
S D Rowley, Z Feng, D Yadock, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 70) with videos related to
Sort By:
Page
of 7
Progress in Clinical and Biological Research
|
January 1, 1992
Incidence of bacterial contamination of bone marrow grafts
K G Schepers, J M Davis, S D Rowley
Blood
|
July 1, 1986
Dye-mediated photolysis of human neuroblastoma cells: implications for autologous bone marrow transplantation
F Sieber, S Rao, S D Rowley, et al.
The American Journal of Pediatric Hematology/Oncology
|
January 1, 1990
Ex vivo chemopurging of autologous bone marrow with 4-hydroperoxycyclophosphamide to eliminate occult leukemic cells. Laboratory and clinical observations
A M Yeager, S D Rowley, H Kaizer, et al.
Blood
|
July 1, 1993
Hematopoietic precursors resistant to treatment with 4-hydroperoxycyclophosphamide: requirement for an interaction with marrow stroma in addition to hematopoietic growth factors for maximal generation of colony-forming activity
S D Rowley, C Brashem-Stein, R Andrews, et al.
Blood
|
March 1, 1987
Culture from human bone marrow of blast progenitor cells with an extensive proliferative capacity
S D Rowley, S J Sharkis, C Hattenburg, et al.
Blood
|
May 1, 1994
Effect of cell concentration on bone marrow and peripheral blood stem cell cryopreservation
S D Rowley, W I Bensinger, T A Gooley, et al.
Bone Marrow Transplantation
|
March 1, 1996
Long-term cryopreservation of bone marrow for autologous transplantation
H Attarian, Z Feng, C D Buckner, et al.
Transfusion Science
|
February 6, 1998
Protein A immunoadsorption in alloimmunized patients refractory to platelet transfusions and in patients with treatment-resistant immune thrombocytopoenic purpura
K Gutensohn, A R Zander, S D Rowley, et al.
Transfusion
|
May 21, 1999
The predictive value of white cell or CD34+ cell count in the peripheral blood for timing apheresis and maximizing yield
J Yu, W Leisenring, W I Bensinger, et al.
Cytotherapy
|
April 30, 2010
Post-thaw removal of DMSO does not completely abrogate infusional toxicity or the need for pre-infusion histamine blockade
S D Rowley, Z Feng, D Yadock, et al.
Page
of 7